FASN and neoplasm: FASN inhibitors, such as cerulenin, C75, orlistat and epigallocatechin gallate (EGCG), demonstrated anti-tumor activity, leading to toxic accumulation of the malonyl-CoA intermediate, reduction of membranes synthesis and phospholipid function.